Ruby Hall Clinic, Pune Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2007
NCT01187966
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

Ruby Hall clinic

Active Ingredients

Drugs in Phase 3 Trials (1)

safinamide (xadago) (1 trial)

Drugs in Phase 2 Trials (1)

allogeneic adipose derived mesenchymal stem cell (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fibrosis (Phase 2)

Liver Cirrhosis (Phase 2)

Liver Cirrhosis, Alcoholic (Phase 2)

Parkinson Disease (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2